RESEARCH & INNOVATION
Over a decade
of virtual care experience
The Essential GLP-1 Companion Program
Support your population across the medication lifecycle.
The path towards a consistent vision requires continuous innovation. Find out how Omada achieves this with product innovation today.
Omada Health’s digital care programs are clinically supported and evidence-based, with results published in multiple peer-reviewed journals.
Delivering on the vision to bend the curve for chronic disease
Clinical
Shaping the future of virtual care
Member Experience
Driving next-level personal care
Partnerships
Strengthening integrated processes
Omada Health
"The real power of digital health comes from an integration between people and technology, and clinicians and technology, versus tech alone."
Omada Insights Lab
The Omada Insights Lab is a hub of continuous innovation, featuring real world data-driven analyses and insights. We evaluate responsible applications of AI and Machine Learning use to support tailored, ethical, and human-led programs. Through the stories our data tells about our member population we demonstrate our commitment to enhancing the program experience for all members in our diverse population.
Omada for Cholesterol
Omada introduces a new cholesterol program to make lipid risk visible, actionable, and sustainable. Members can receive cholesterol support on its own, or alongside other cardiometabolic care.
Omada’s GLP-1 companion program helps members achieve lasting weight health
GLP-1s are Changing How Americans Get Healthcare—and Employers are at the Center
We’re living through one of the biggest shifts in employer‑sponsored healthcare in decades, and GLP‑1 medications are the clear conduit.
Meet the New Heart Health Tech Stack: AI, Cuffless Monitors, and Behavior Change
Find out how AI-powered tools are transforming cardiovascular health and supporting sustainable heart-healthy behavior change.
The path towards a consistent vision requires continuous innovation. Find out how Omada achieves this with product innovation today.
Omada Health’s digital care programs are clinically supported and evidence-based, with results published in multiple peer-reviewed journals.
GLP-1 Resources
Keep up with Omada
Disclaimer
The no cost CGM sensors exclude Medicare, Medicaid, and other government payers. The Abbott FreeStyle Libre 14 day system is available to eligible participants with a valid prescription and compatible smartphone. Setup is required for continuous glucose monitoring. The circular shape of the sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. FreeStyle Libre 14 day system: Failure to use FreeStyle Libre 14 day system as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If readings do not match symptoms or expectations, use a finger stick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety info.